JPRN-UMIN000003236
Completed
未知
Cinacalcet for the treatment of hypercalcemia with persistent hyperparathyroidism in renal transplant recipients: a case siries study. - Cinacalcet for the treatment of hypercalcemia with persistent hyperparathyroidism in renal transplant recipients: a case siries study.
St Marianna University0 sites15 target enrollmentFebruary 26, 2010
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Hypercalcemia with persistent hyperparathyroidism in renal transplant recipients.
- Sponsor
- St Marianna University
- Enrollment
- 15
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.age below 20 years old or pregnant 2\.those who cannot agree to the study 3\.inappropriate patients judged by primary or study physicians. 4\.history of allergy or severe side effects by cinacalcet 5\.those with severe liver dysfunction 6\.concomitant use of vitamin D sterols, phosphate binder, calcium supplementation, bisphosphonates within 2 weeks before start of the study 7\.history of parathyroidectomy or percutaneous ethanol injection therapy to parathyroid glands.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Efficacy and safety of the calcimimetic Cinacalcet in the management of patients with Primary Hyperparathyroidism due to a MEN-1 mutation - Cinacalcet in MEN-I PHPTPatients with primary hyperparathyroidism due to a germline mutation in the MEN-1 geneMedDRA version: 12.1Level: LLTClassification code 10036693Term: Primary hyperparathyroidismEUCTR2010-018861-53-NLeiden University Medical Center
Completed
Phase 4
Efficacy and safety of treatment with Cinacalcet in patients with Primary Hyperparathyroidism due to a MEN-1 mutatiohyperactive parathyroid glandsprimary hyperparathyroidism1008362410033949NL-OMON34871eids Universitair Medisch Centrum20
Completed
Not Applicable
Cinacalcet and concurrent intravenous calcitriol for treatment of secondary hyperparathyroidism in dialysis patients compared with intravenous calcitriol alonesecondary hyperparathyroidismJPRN-UMIN0000034381.Division of Internal medicine, Seseragi hospital 2.Department of Medicine & Biological Science Gunma University Graduate School of Medicine100
Completed
Not Applicable
A combination of cinacalcet with maxacalcitol for regression of moderate to advanced secondary hyperparathyroidism in patients on chronic hemodialysissecondary hyperparathyroidismJPRN-UMIN000001478Kitano Hospital Division of Nephrology and Dialysis50
Active, not recruiting
Phase 1
Study to Investigate Cinacalcet Treatment in Haemodialysis Patients with Secondary Hyperparathyroidism - SENSOREUCTR2004-002310-10-ESAmgen Development Europe800